The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...

Clearside Biomedical, Inc. has announced the presentation of two subgroup analyses from its ODYSSEY Phase 2b clinical trial ... advancement in the company's research portfolio.

A multi-disciplinary team of experts has initiated a crucial research project aimed at understanding and addressing the ...

A multi-disciplinary team of experts has commenced an essential research project aimed at understanding and addressing the ...

Universities are scrambling after the National Institutes of Health announced a plan to cut millions of dollars in research ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Perhaps nowhere is reproducibility more integral to a study’s relevance and success than in biomedical and translational research. After all ... leaving this critical evaluation to Phase 3 trials and ...

Blue Cross and Blue Shield of Kansas announced a $2.5 million donation at a Monday ceremony at WSU’s Marcus Welcome Center.

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

Union Minister Dr. Jitendra Singh today launched Automated Bio Medical Waste Treatment Plant at AIIMS New Delhi. The ...

Share on Facebook Share on Twitter Blue Cross and Blue Shield of Kansas has announced a $2.5 million donation to Wichita ...